The 40 references in paper H.-J. Gröne , E. Kiss , Г.-Й. Грене, Е. Кисс (2008) “НЕФРОТИЧЕСКИЙ СИНДРОМ: ГИСТОПАТОЛОГИЧЕСКАЯ ДИФФЕРЕНЦИАЛЬНАЯ ДИАГНОСТИКА. ЧАСТЬ 3: МЕМБРАНОЗНО-ПРОЛИФЕРАТИВНЫЙ ГЛОМЕРУЛОНЕФРИТ, IgA НЕФРОПАТИЯ, ДИАБЕТИЧЕСКАЯ НЕФРОПАТИЯ, АМИЛОИДОЗ, ПОСТРАНСПЛАНТАЦИОННАЯ НЕФРОПАТИЯ // NEPHROTIC SYNDROME: HISTOPATHOLOGICAL DIFFERENTIAL DIAGNOSTICS. PART 3: MEMBRANOUS PROLIFERATIVE GLOMERULONEPHRITIS, IGA NEPHROPATHY, DIABE TIC NEPHROPATHY, AMYLOIDOSIS, POST-TRANSPLANT NEPHROPATHY” / spz:neicon:nefr:y:2008:i:1:p:84-97

1
Andresdottir MB, Assmann KJ, Koene RA, Wetzels JF. Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy. Am J Kidney Dis 1998; 32: 582-588
(check this in PDF content)
2
Bariety J, Nochy D, Mandet C et al. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 1998;53:918-925
(check this in PDF content)
3
Benigni A, Gagliardini E, Tomasoni S et al. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy.Kidney Int 2004; 65:2193-2200
(check this in PDF content)
4
Cameron JS. Focal segmental glomerulosclerosis in adults. Nephrol Dial Transplant 2003;18[suppl 6]:vi 45-51
(check this in PDF content)
5
D’Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2004;43:368-382
(check this in PDF content)
6
Grone EF, Walli AK, Grone HJ et al. The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 1994;107: 1-13
(check this in PDF content)
7
Grone HJ, Grone EF, Malle E. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis. Lab Invest 2002;
(check this in PDF content)
8
1): 5-14 8. Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002; 6;346:1786- 1791
(check this in PDF content)
9
Heidet L, Bongers EM, Sich M et al. In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys. Am J Pathol 2003;163:145-155
(check this in PDF content)
10
Janssen B, Hohenadel D, B rinkkoetter P et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 2005; 54 :2320-2327
(check this in PDF content)
11
Kaplan JM, Kim SH, North KN et al. Mutations in ACTN4, encoding alpha-actinin-4, cause fam ilial focal segmental glomerulosclerosis. Nat Genet 2000; 24:251-256
(check this in PDF content)
12
Kriz W. Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 2002; 15; 57:189-195
(check this in PDF content)
13
Kriz W. The pathogenesis of ‘classic’ focal segmental glomerulosclerosis-lessons from rat models. Nephrol Dial Transplant 2003; 18[Suppl 6]: vi39-44
(check this in PDF content)
14
Lachmann HJ, Booth DR, Booth SE et al. Congenital nephrotic syndromes. Curr Opin Genet Dev 2001; 11: 322-327
(check this in PDF content)
15
Lahdenkari AT, Kestila M, Holmberg C et al. Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS).Kidney Int 2004; 65:1856-1863
(check this in PDF content)
16
Malle E, Buch T, Grone HJ. Myeloperoxidase in kidney disease.Kidney Int 2003; 64: 1956-1967
(check this in PDF content)
17
Markowitz GS, Schwimmer JA, Stokes MB et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 2003; 64:1232-1240
(check this in PDF content)
18
Marx BE, Marx M. Prediction in idiopathic membranous nephropathy. Kidney Int 1999; 56:666-673
(check this in PDF content)
19
Matsuda M, Shikata K, Wada J et al. Deposition of mannan binding protein and mannan binding protein- mediated complement activation in the glomeruli of patients with IgA nephropathy. Nephron 1998; 80:408-413
(check this in PDF content)
20
Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med 2004; 255:159-178
(check this in PDF content)
21
Morello R, Lee B. Insight into podocyte differentiation from the study of human genetic disease: nail-patella syndrom e and transcriptional regulation in podocytes. Pediatr Res 2002;51: 551-558
(check this in PDF content)
22
Moudgil A, Nast CC, Bagga A et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 2001; 59: 2126-2133
(check this in PDF content)
23
Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002; 13:3005-3015
(check this in PDF content)
24
Miner JH, Morello R, Andrews KL et al. Transcriptional induction of slit diaphragm genes by Lmx1b is required in podocyte differentiation. J Clin Invest 2002;109: 1065-1072
(check this in PDF content)
25
Niaudet P Genetic forms of nephrotic syndrome. Pediatr Nephrol 2004; 21
(check this in PDF content)
26
Sellin L, Huber TB, Gerke P et al. NEPH1 defines a novel fam ily of podocin interacting proteins. FASEB J 2003;17:115-117
(check this in PDF content)
27
Somlo S, Mundel P Getting a foothold in nephrotic syndrome. Nat Genet 2000; 24: 333-335
(check this in PDF content)
28
Stokes MB, Markowitz GS, Lin J et al. Glomerular tip lesion: a distinct entity within the minimal change disease/ focal segmental glomerulosclerosis spectrum. Kidney Int 2004; 65: 1690-1702
(check this in PDF content)
29
Berg JG, van den Bergh Weerman MA, Assmann KJ et al. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 2004; 66:1901-1906
(check this in PDF content)
30
Berg JG, Weening JJ. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci (Lond) 2004; 107: 125-136
(check this in PDF content)
31
Dijk C, Berl T. Pathogenesis of diabetic nephropathy. Rev Endocr Metab Disord 2004; 5:237-248
(check this in PDF content)
32
W olf G, Stahl RA. CD2-associated protein and glomerular disease. Lancet 2003; 362:1746-1748
(check this in PDF content)
33
Yakupoglu U, Baranowska-Daca E, Rosen D et al. P ost-transplant nephrotic syndrome: A comprehensive clinicopathologic study. Kidney Int 2004; 65:2360-2370
(check this in PDF content)
34
Frasca GM, Soverini L, Gharavi AG et al. Thin basement membrane disease in patients with familial IgA nephropathy. J Nephrol 2004; 17: 778-7785
(check this in PDF content)
35
Suliman ME, Stenvinkel P, Barany P et al. Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients. Semin Nephrol 2006; 26(1): 14-19
(check this in PDF content)
36
Suissa S, Hutchinson T, Brophy JM, Kezouh A. ACE- inhibitor use and the long-term risk of renal failure in diabetes. Kidney Int 2006; 69: 913-919
(check this in PDF content)
37
Thomas DB, Franceschini N, Hogan SL et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 2006; 69:920-926
(check this in PDF content)
38
Tisher CC, Brenner BM. Renal pathology with clinical and functional correlations. 1 ed. J.B. Lipincott Company, 1993
(check this in PDF content)
39
Heptinstall RH. Pathology of the kideny. 3rd ed. Little, Brown Co, 1983 Приложение 1. Формы амилоидоза. Амилоидный протеин ПредшественникСистемный (S) или локализованный (L) Синдром или вовлеченная ткань ALЛегкие цепи иммуноглобулинаS, LПервичный Миелома-ассоциированный AHТяжелые цепи иммуноглобулинаS, LПервичный Миелома-ассоциированный Семейный ATTRТранстиреринSСнильный системный Ap2MР2-микроглобулинSГемодиализ AA(Apo) сывороточный AASВторчиный, реактивный AApoA-IАполипопротеин A-ISСемейный AApoA-IIАполипопротеин A-IISСемейный AGelГесолин (Gelsolin)SСемейный ALysЛизозим (Lysozyme)SСемейный AFibФибриноген а-цепьSСемейный ACysЦистатин CSСемейный ABriABriPPLСемейная деменция ADanADanPPLСемейная деменция APAp белковый предшественник (AвPP)LБолезь Альцгеймера, ста
(check this in PDF content)
40
х) увеличении. Клубочек имеет повышенную увеличенную мезангиальную и лейкоцитарную клеточность. Наблюдаются лобулярная акцентуация, сегментарное увеличение мезангиального матрикса и утолщенные двухконтурные капиллярные стенки («трамвайные рельсы») периферических капиллярныых стенок (PAS). Иммуногистохимия (C, D): диффузное гломе­ рулярное прокрашивание периферических капиллярных стенок и мезангия на C3 (C и D, увеличение 200х и 400х, соответ- ствено).
(check this in PDF content)